15 research outputs found

    Biomechanical study on kicking movement in soccer players by motion capture system

    Get PDF
    J-GLOBAL ID : 202001012478363111J-GLOBAL ID : 202101011515064120J-GLOBAL ID : 201501027844069716J-GLOBAL ID : 2014010795332072711520860078899386240application/pdfdepartmental bulletin pape

    Development of a new disinfection system that does not affect the health of athletes : (Effects of different pH values on lung-derived human fibroblasts : results of cell staining)

    Get PDF
    J-GLOBAL ID : 201801018102090530J-GLOBAL ID : 202101016459819581J-GLOBAL ID : 202001012478363111J-GLOBAL ID : 200901064795229350J-GLOBAL ID : 202101008813409997J-GLOBAL ID : 2017010081302482511520578603922184064application/pdfdepartmental bulletin pape

    夢をあきらめない

    No full text
    ・競技を始めた (出会った) きっかけ ・学生時代の夢 ・現役 (選手) 時代の夢 ・選手を引退した時の意思決定  ※ターニングポイント ・進学 (学位) や就職 (進路) など ・これからの学生へのメッセージ日時 : 2021年3月8日 (月) 9:00~ オンライン配信 配信場所 : manabaapplication/pd

    Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension

    No full text
    Abstract Objective To evaluate the long‐term efficacy, safety, and tolerability of adjunctive perampanel for the treatment of patients with refractory focal‐onset seizures (FOS), with or without focal to bilateral tonic–clonic seizures (FBTCS), from the Asia‐Pacific region. Methods Study 335 (NCT01618695) was a randomized, double‐blind, placebo‐controlled, Phase III study. Patients aged ≥12 years with refractory FOS who completed the Core Study could enter an open‐label extension (OLEx) Phase (6‐week Conversion and ≥46‐week Maintenance Period). Endpoints included median percent reduction in seizure frequency per 28 days, 50% responder and seizure‐freedom rates, and treatment‐emergent adverse events (TEAEs). Results The Intent‐to‐Treat Analysis Set included 704 patients (529 received perampanel and 175 received placebo during the Core Study; all patients received perampanel during OLEx). The median percent reduction in seizure frequency and 50% responder rates in patients who received perampanel during the Core Study were maintained throughout the OLEx Phase (Week 64–75: 55.9% and 54.3%, respectively). Seizure freedom for ≥12 consecutive months at any time during perampanel treatment was achieved by 4.1% of patients with FOS and 14.2% of patients with FBTCS. Among patients treated with perampanel 4 mg/day (n = 83), median reduction in seizure frequency was lower in those who received concomitant enzyme‐inducing anti‐seizure medications (EIASMs) than those who received non‐EIASMs. The most common TEAE was dizziness (n = 318; 46.8%); 141 (20.8%) patients had TEAEs that led to study/drug withdrawal. Significance Overall, long‐term seizure control was achieved with adjunctive perampanel in patients with refractory FOS, with or without FBTCS, in an Asia‐Pacific population

    Control of Submillimeter Phase Transition by Collective Photothermal Effect

    No full text
    Local molecular states and biological materials in small spaces ranging from the microscale to nanoscale can be modulated for medical and biological applications using the photothermal effect (PTE). However, there have been only a few reports on exploiting the collective phenomena of localized surface plasmons (LSPs) to increase the amount of light-induced heat for the control of material states and the generation of macroscopic assembled structures. Here, we clarify that microbeads covered with a vast number of Ag nanoparticles can induce a large PTE and generate a submillimeter bubble within several tens of seconds under the synergetic effect of the light-induced force (LIF) and photothermal convection enhanced by collective phenomena of LSPs. Control of the phase transition induced by such a “collective photothermal effect” enables rapid assembling of macroscopic structures consisting of nanomaterials, which would be used for detection of a small amount of proteins based on light-induced heat coagulation
    corecore